Pediatric Genetic and Metabolic Disorders

51 soru

Tüm türler51 Çoktan seçmeli25 Eşleştirme12 Sıralama14

A $4$ -year-old boy is evaluated in the genetics clinic due to developmental delay and behavioral changes. His parents report that his early milestones were met on time, but over the past year, he has become increasingly hyperactive, aggressive, and his speech has regressed. Physical examination reveals a child with coarse facial features, a prominent forehead, and a widened nasal bridge. Abdominal examination demonstrates a liver edge palpable $4 \text{ cm}$ below the right costal margin and a palpable spleen. Musculoskeletal examination shows joint stiffness with decreased range of motion in the elbows, wrists, and knees. An ophthalmologic evaluation reveals clear corneas bilaterally without evidence of clouding. Which of the following is the most likely diagnosis?

Hunter syndrome

Hurler syndrome

Gaucher disease

Niemann-Pick disease

Tay-Sachs disease

Cevabı ve açıklamayı göster

Cevap: Hunter syndrome

Cevap

Hunter syndrome

The patient's presentation of developmental regression, coarse facial features, hepatosplenomegaly, and joint contractures without corneal clouding is characteristic of Hunter syndrome (mucopolysaccharidosis type II). It is an X-linked recessive lysosomal storage disorder caused by a deficiency of iduronate-2-sulfatase.

Adım Adım Çözüm

Analyze the clinical presentation for syndromic features.

The patient has coarse facial features, hepatosplenomegaly, joint contractures, and developmental regression.

Identifying the constellation of physical and developmental signs points toward a mucopolysaccharidosis (MPS).

Evaluate the ophthalmologic findings.

The corneas are clear without any clouding.

The presence or absence of corneal clouding is the key differentiating feature between Hurler syndrome (MPS I) and Hunter syndrome (MPS II).

Synthesize the findings to establish the diagnosis.

The correct diagnosis is Hunter syndrome.

Hunter syndrome matches all clinical findings, specifically the lack of corneal clouding which rules out Hurler syndrome.

Anahtar Kavram

Hunter syndrome (Mucopolysaccharidosis type II)

Soru 2Soru →

A 4-day-old male neonate is brought to the emergency department due to poor feeding, vomiting, and progressive unresponsiveness over the past 12 hours. He was born at 39 weeks gestation via uncomplicated vaginal delivery and was discharged on day 2 of life feeding well. On examination, the infant is comatose, hypothermic (35.4°C), and tachypneic. While being examined, he develops generalized tonic-clonic seizure activity. Initial laboratory evaluation reveals:

Sodium: 140 mEq/L
Potassium: 4.5 mEq/L
Chloride: 105 mEq/L
Bicarbonate: 22 mEq/L
Blood urea nitrogen: 4 mg/dL
Creatinine: 0.3 mg/dL
Glucose: 55 mg/dL
Arterial blood gas: pH 7.52, pCO2 25 mmHg, pO2 95 mmHg
Plasma ammonia: 1,250 µmol/L (normal: 15-50 µmol/L)

Arrange the following management steps in the most appropriate sequential order for this patient.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is: (1) endotracheal intubation, (2) discontinue feeds and start IV dextrose, (3) draw diagnostic labs, (4) administer IV nitrogen scavengers, (5) initiate emergency hemodialysis.

In a severe neonatal metabolic crisis presenting with extreme hyperammonemia (indicative of a Urea Cycle Defect given the respiratory alkalosis and normal anion gap), management must follow strict emergency protocols. The airway must be secured first due to coma and seizures. Next, the catabolic state must be reversed by stopping protein and giving dextrose. Diagnostic labs must then be drawn, because subsequent treatments will erase the biochemical evidence needed for a definitive diagnosis. After labs are secured, medical therapies (scavengers) are initiated because they are readily available. Finally, preparation for emergency hemodialysis is completed, which is the definitive treatment for ammonia levels this high (>1,000 µmol/L) but takes the longest to physically initiate.

Adım Adım Çözüm

Assess clinical stability and prioritize ABCs (Airway, Breathing, Circulation).

Identify that the comatose and seizing neonate requires immediate endotracheal intubation to protect the airway.

Neurologic compromise from cerebral edema impairs airway protective reflexes and respiratory drive.

Address the immediate pathophysiologic driver (hyperammonemia).

Discontinue breast milk/formula (protein source) and provide high-concentration IV dextrose.

Halting protein intake and providing carbohydrates stimulates insulin release, shifting the body from a catabolic state (breaking down internal proteins, releasing ammonia) to an anabolic state.

Secure diagnostic integrity before definitive treatment.

Draw plasma amino acids, urine organic acids, and acylcarnitine profile.

Once nitrogen scavengers or dialysis are started, the specific metabolic signature required to diagnose the exact enzyme deficiency (e.g., Ornithine Transcarbamylase deficiency) will be washed out.

Initiate medical therapy for hyperammonemia.

Administer sodium benzoate, sodium phenylacetate, and arginine.

These medications provide alternative pathways for nitrogen excretion and prime the urea cycle; they can be pushed quickly via IV.

Initiate definitive mechanical clearance of ammonia.

Perform emergency hemodialysis.

Ammonia levels >500 µmol/L in a neonate correlate with severe brain edema and poor neurologic outcomes. Hemodialysis is the fastest way to clear ammonia but takes time to set up, placing it at the end of the immediate stabilization sequence.

Anahtar Kavram

Acute management of neonatal hyperammonemic crisis prioritizes airway stabilization, reversal of catabolism, collection of diagnostic labs prior to treatment, pharmacologic scavenging, and finally, emergency hemodialysis for extreme levels.

Soru 3Soru →

A medical student is reviewing the pathophysiology of several pediatric genetic and metabolic disorders during a clinical genetics rotation. Evaluate the clinical vignettes below and match each patient presentation with the most accurate description of its underlying biochemical or genetic defect.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Cevabı ve açıklamayı göster

Cevap

The correct pairings connect Homocystinuria with impaired cystathionine synthesis, Lesch-Nyhan syndrome with defective purine salvage, Tay-Sachs disease with GM2 ganglioside accumulation, and Hunter syndrome with iduronate-2-sulfatase deficiency.

Each vignette provides unique diagnostic clues that point to a specific biochemical defect. The tall patient with thrombosis and downward lens subluxation has homocystinuria. The boy with self-mutilation has Lesch-Nyhan syndrome. The infant with a cherry-red spot and no organomegaly has Tay-Sachs disease. The boy with coarse facies and clear corneas has Hunter syndrome.

Adım Adım Çözüm

Analyze the first vignette for classic physical and historical findings.

Identifies homocystinuria.

Downward lens subluxation and thrombosis in a patient with a Marfanoid habitus and intellectual disability are pathognomonic for homocystinuria, resulting from impaired homocysteine to cystathionine conversion.

Evaluate the second vignette's unique behavioral and laboratory clues.

Identifies Lesch-Nyhan syndrome.

Self-mutilation (lip/finger biting), choreoathetosis, and uric acid crystals (orange sand) indicate a purine metabolism defect due to absent HGPRT.

Differentiate the third vignette from similar lysosomal storage diseases.

Identifies Tay-Sachs disease.

A macular cherry-red spot without hepatosplenomegaly and an exaggerated startle reflex point to Hexosaminidase A deficiency rather than Niemann-Pick disease.

Distinguish the mucopolysaccharidosis in the fourth vignette.

Identifies Hunter syndrome.

Coarse facial features and joint stiffness with clear corneas (unlike Hurler syndrome) and nodular skin lesions strongly indicate MPS II, caused by iduronate-2-sulfatase deficiency.

Anahtar Kavram

Clinical recognition and biochemical correlation of classical pediatric metabolic and genetic disorders (Homocystinuria, Lesch-Nyhan, Tay-Sachs, Hunter).

Soru 4Soru →

Match each pediatric patient's clinical presentation with the most appropriate targeted vitamin or cofactor supplementation that serves as specific therapy for their likely underlying metabolic condition.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Cevabı ve açıklamayı göster

Cevap

The correct pairings match each inborn error of metabolism with its corresponding deficient enzyme's targeted cofactor: Methylmalonic acidemia with Cobalamin (Vitamin B12), Homocystinuria with Pyridoxine (Vitamin B6), Maple syrup urine disease with Thiamine (Vitamin B1), and Biotinidase deficiency with Biotin (Vitamin B7).

Each clinical vignette describes a classic presentation of an inborn error of metabolism that can be treated with high-dose targeted vitamin cofactor therapy. Methylmalonic acidemia (methylmalonyl-CoA mutase deficiency) responds to cobalamin (B12); homocystinuria (cystathionine beta-synthase deficiency) to pyridoxine (B6); maple syrup urine disease (branched-chain ketoacid dehydrogenase complex deficiency) to thiamine (B1); and biotinidase deficiency to biotin (B7).

Adım Adım Çözüm

Analyze the first vignette to identify the metabolic disorder.

Elevated methylmalonic acid, metabolic acidosis, and hyperammonemic encephalopathy indicate methylmalonic acidemia.

Identifying the disorder is necessary to determine the required enzyme cofactor.

Determine the therapeutic cofactor for methylmalonic acidemia.

The required cofactor for methylmalonyl-CoA mutase is cobalamin (Vitamin B12).

Mutations affecting cofactor binding can often be treated with high-dose vitamin supplementation.

Analyze the second vignette.

Downward lens subluxation, marfanoid habitus, and intellectual disability are hallmarks of homocystinuria.

Recognizing distinguishing features (downward versus upward lens subluxation) separates this from purely structural connective tissue disorders.

Identify the therapeutic cofactor for homocystinuria.

Cystathionine beta-synthase requires pyridoxine (Vitamin B6).

A significant percentage of homocystinuria patients are B6-responsive.

Evaluate the third vignette.

A sweet urine odor and elevated branched-chain amino acids (leucine, isoleucine, valine) indicate maple syrup urine disease (MSUD).

MSUD is caused by deficiency of the branched-chain ketoacid dehydrogenase complex.

Identify the relevant cofactor for the MSUD enzyme complex.

Thiamine (Vitamin B1) is a required cofactor.

The branched-chain ketoacid dehydrogenase complex utilizes thiamine pyrophosphate for its catalytic activity.

Evaluate the fourth vignette and match its cofactor.

Alopecia, periorificial rash, and hypotonia indicate biotinidase deficiency, which is treated with Biotin (Vitamin B7).

Biotinidase recycles biotin; its absence causes multiple carboxylase deficiency, entirely preventable with biotin supplementation.

Anahtar Kavram

Many inborn errors of metabolism can be managed by administering pharmacologic doses of the specific vitamin or cofactor required by the deficient or dysfunctional enzyme.

Tahmini Süre:1m 30s

Soru 5Soru →

Review the following distinct clinical presentations of pediatric genetic syndromes. Match each patient's phenotypic description with the most appropriate underlying diagnosis.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Cevabı ve açıklamayı göster

Cevap

The presentations map respectively to Prader-Willi syndrome, Angelman syndrome, Williams syndrome, Fragile X syndrome, and DiGeorge syndrome.

Each syndrome described has unique and highly testable phenotypic markers: Prader-Willi is marked by a biphasic feeding/weight pattern; Angelman by neurobehavioral features like spontaneous laughter and seizures; Williams by hypersociability and elastin-related vascular issues; Fragile X by characteristic physical traits like macroorchidism; and DiGeorge by developmental field defects affecting the pharyngeal pouches.

Adım Adım Çözüm

Analyze the first vignette focusing on the biphasic feeding/weight pattern.

Neonatal hypotonia followed by hyperphagia indicates Prader-Willi syndrome.

This is the classic developmental trajectory for patients missing paternal expression at 15q11-q13.

Analyze the second vignette focusing on behavior and movement.

Inappropriate laughter, severe speech delay, and ataxia point to Angelman syndrome.

These are the pathognomonic neurobehavioral features of this maternal deletion syndrome.

Analyze the third vignette focusing on personality and cardiac findings.

An overly outgoing personality and supravalvular aortic stenosis confirm Williams syndrome.

The deletion of the elastin gene on chromosome 7 accounts for the specific vascular pathology, coupled with the unique behavioral phenotype.

Analyze the fourth vignette focusing on physical traits in an adolescent male.

Large protruding ears and macroorchidism identify Fragile X syndrome.

These are the hallmark post-pubertal physical findings associated with the FMR1 gene mutation.

Analyze the fifth vignette focusing on neonatal metabolic and structural anomalies.

Tetany from hypocalcemia combined with a conotruncal defect strongly suggests DiGeorge syndrome.

Defective development of the third and fourth pharyngeal pouches leads to absent/hypoplastic parathyroid glands and characteristic cardiac outflow tract anomalies.

Anahtar Kavram

Clinical diagnosis of pediatric genetic and microdeletion syndromes based on characteristic physical, behavioral, and metabolic phenotypes.

Soru 6Soru →

Parents bring their $6$ -month-old daughter to the acute care clinic due to episodes of profound sweating, vomiting, and unresponsiveness. According to the parents, the infant was entirely asymptomatic during her first few months of life while being exclusively breastfed. However, following the introduction of fruit purees and apple juice three weeks ago, she began having these episodes shortly after feeding. Vital signs include a heart rate of $152$ /min and a respiratory rate of $42$ /min. Physical examination demonstrates a pale, difficult-to-arouse infant with marked hepatomegaly.

The following laboratory findings are reported:

Laboratory Test	Result	Reference Range
Capillary blood glucose	$38$ mg/dL	$70$ - $100$ mg/dL
Serum lactate	$4.8$ mmol/L	$0.5$ - $2.2$ mmol/L
Serum uric acid	$8.2$ mg/dL	$2.0$ - $5.5$ mg/dL
Urinalysis (glucose oxidase)	Negative	Negative
Urinalysis (reducing substances)	Positive	Negative

Which of the following is the most likely underlying biochemical defect in this patient?

Decreased fructokinase activity

Accumulation of galactose-1-phosphate

Impaired cleavage of fructose-1-phosphate

Defective transport of glucose-6-phosphatase

Impaired conversion of pyruvate to acetyl-CoA

Cevabı ve açıklamayı göster

Cevap: Impaired cleavage of fructose-1-phosphate

Cevap

Impaired cleavage of fructose-1-phosphate

The correct answer is impaired cleavage of fructose-1-phosphate, which causes hereditary fructose intolerance (Aldolase B deficiency). This autosomal recessive condition typically presents when fructose-containing foods (such as fruit purees and juices) are first introduced into an infant's diet, usually around

4

6

months of age. The deficiency of Aldolase B leads to an accumulation of fructose-1-phosphate in the liver, which depletes intracellular ATP and inorganic phosphate. This depletion ultimately inhibits both glycogenolysis and gluconeogenesis, resulting in severe hypoglycemia. Clinical manifestations include recurrent vomiting, diaphoresis, lethargy, and hepatomegaly following meals. Laboratory tests classically show hypoglycemia, lactic acidosis, hyperuricemia, and the presence of fructose in the urine, which is detected as a positive non-glucose reducing substance.

Adım Adım Çözüm

Analyze the onset of symptoms and dietary triggers.

The infant was healthy while exclusively breastfed but developed severe symptoms upon the introduction of fruit purees and juices at 6 months of age.

Identifying the dietary trigger (fructose vs. lactose) is critical for narrowing down the category of inborn error of metabolism.

Interpret the laboratory findings.

The patient has severe hypoglycemia, lactic acidosis, hyperuricemia, and non-glucose reducing substances in the urine (positive reducing substances with negative glucose oxidase).

Non-glucose reducing substances point to either galactosemia or a fructose metabolism disorder. The presence of severe systemic symptoms (acidosis, hypoglycemia) rules out benign conditions.

Synthesize findings to identify the underlying defect.

The combination of fructose-induced severe hypoglycemia, hepatomegaly, and metabolic acidosis confirms Hereditary Fructose Intolerance, caused by Aldolase B deficiency.

Aldolase B normally cleaves fructose-1-phosphate. Its deficiency leads to toxic accumulation of fructose-1-phosphate and depletion of intracellular ATP.

Anahtar Kavram

Hereditary fructose intolerance (Aldolase B deficiency) presents with severe hypoglycemia, lactic acidosis, hepatomegaly, and vomiting following the dietary introduction of fructose (e.g., fruit purees, juices). It typically causes non-glucose reducing substances to appear in the urine.

Soru 7Soru →

A 3-year-old boy is brought to the pediatrician by his parents due to worsening behavioral outbursts and a decline in his communication skills. Over the past year, he has stopped using two-word phrases and has become increasingly hyperactive and aggressive. The parents also report that he has "noisy breathing," chronic nasal discharge, and recurrent wheezing that has not improved with multiple trials of inhaled albuterol. His medical history is notable for bilateral inguinal hernia repairs at age 1. Vital signs are within normal limits. Physical examination reveals a macrocephalic child with prominent supraorbital ridges, a broad nose, and a large tongue. Abdominal examination demonstrates a firm liver edge 4 cm below the right costal margin and a palpable splenic tip. Skin examination reveals distinct, grouped, ivory-colored papules over the scapular region. Slit-lamp examination of the eyes shows perfectly clear corneas. Laboratory studies show a serum thyroid-stimulating hormone (TSH) of 2.1 µU/mL (normal: 0.5–5.0 µU/mL). Which of the following is the most likely underlying etiology of this patient's condition?

Deficiency of alpha-L-iduronidase

Bronchial smooth muscle hyperreactivity

Deficiency of iduronate-2-sulfatase

Thyroid gland dysgenesis

Disseminated cutaneous viral infection

Cevabı ve açıklamayı göster

Cevap: Deficiency of iduronate-2-sulfatase

Cevap

Deficiency of iduronate-2-sulfatase

The patient's presentation of developmental regression, severe hyperactivity, coarse facial features, hepatosplenomegaly, hernias, and clear corneas is classic for Hunter syndrome (Mucopolysaccharidosis type II). The ivory-colored, grouped papules over the scapular region are known as 'Hunter papules' and are a rare but pathognomonic finding for this disease. Hunter syndrome is an X-linked recessive disorder caused by a deficiency of iduronate-2-sulfatase, which leads to the toxic accumulation of heparan sulfate and dermatan sulfate in various tissues. The tissue accumulation in the airways also accounts for his noisy breathing and unresponsiveness to asthma medications.

Adım Adım Çözüm

Analyze the patient's physical and developmental findings.

The patient has a syndromic presentation consisting of developmental regression, coarse facial features, macroglossia, hepatosplenomegaly, hernias, and specific skin papules.

Synthesizing these multi-system findings is required to narrow the differential diagnosis to a metabolic storage disorder, specifically a mucopolysaccharidosis (MPS).

Differentiate between the distinct types of mucopolysaccharidoses.

The presence of perfectly clear corneas and grouped, ivory-colored scapular papules (Hunter papules) distinguishes this condition from MPS I (Hurler syndrome).

Corneal clouding is a critical physical exam discriminator that is present in Hurler syndrome but characteristically absent in Hunter syndrome.

Identify the specific biochemical defect responsible for the identified syndrome.

Hunter syndrome is caused by a deficiency in iduronate-2-sulfatase.

This specific enzyme deficiency leads to the tissue accumulation of heparan sulfate and dermatan sulfate, directly causing the unique clinical phenotype.

Anahtar Kavram

Hunter syndrome (Mucopolysaccharidosis Type II) is an X-linked recessive lysosomal storage disease caused by iduronate-2-sulfatase deficiency. It is distinguished from Hurler syndrome by the absence of corneal clouding and the presence of pathognomonic grouped, ivory-colored skin papules.

Tahmini Süre:1m 30s

Soru 8Soru →

A $6$ -day-old term neonate is brought to the pediatric emergency department presenting with progressive lethargy, a weak suck, and recurrent emesis over the past $24$ hours. On physical examination, the infant is hypotonic, difficult to arouse, and exhibits deep, rapid respirations. Initial laboratory studies reveal a severe high anion gap metabolic acidosis, significant ketonuria, and a plasma ammonia level of $320 \mu\text{mol/L}$ (normal: $10-50 \mu\text{mol/L}$ ). The clinical picture is highly suspicious for an acute metabolic crisis secondary to an underlying organic acidemia.

Arrange the following management and diagnostic steps in the most appropriate, chronologically prioritized sequence for this patient.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct prioritized sequence for managing an acute neonatal metabolic crisis is: 1) Discontinue all enteral feedings, 2) Draw critical laboratory samples, 3) Initiate high-concentration intravenous dextrose, 4) Administer empiric metabolic therapies (e.g., L-carnitine), and 5) Consult for urgent hemodialysis.

The correct sequence prioritizes preventing further harm (making the patient NPO), securing a diagnosis before the biochemical state is altered by treatment (drawing critical labs), initiating primary life-saving therapy to stop endogenous toxin production (IV dextrose), adding adjunctive clearance medications (L-carnitine), and finally escalating to mechanical clearance (hemodialysis) if the patient deteriorates.

Adım Adım Çözüm

Halt exogenous protein intake.

Prevents further absorption and breakdown of dietary amino acids.

Dietary protein directly fuels the production of toxic organic acids and ammonia in affected infants.

Obtain the 'critical sample' for diagnosis.

Secures diagnostic metabolic laboratories (acylcarnitines, organic acids).

Intravenous dextrose will rapidly correct the catabolic state, potentially normalizing the biochemical profile and masking the underlying diagnosis if labs are drawn later.

Reverse catabolism with intravenous glucose.

Endogenous protein breakdown is stopped.

High-concentration dextrose stimulates insulin release, which drives anabolism and prevents the body from breaking down its own proteins into toxic metabolites.

Enhance toxin clearance medically.

Toxic metabolites are conjugated and excreted via urine.

Scavenger medications like L-carnitine bind to toxic acyl groups, forming acylcarnitines that can be safely excreted by the kidneys.

Prepare for mechanical toxin removal.

Rapid extracorporeal clearance of severe hyperammonemia.

Required if aggressive medical management is insufficient to prevent irreversible neurologic damage from prolonged hyperammonemia and severe acidosis.

Anahtar Kavram

The acute management of neonatal metabolic crises requires a strict sequence: halting exogenous protein, securing diagnostic 'critical samples', reversing catabolism with high-dose glucose, initiating scavenger therapies, and escalating to hemodialysis if refractory.

Soru 9Soru →

A $14$ -month-old girl is brought to the emergency department due to progressive lethargy, vomiting, and rapid breathing over the past $24$ hours. Two days ago, she developed a mild viral upper respiratory tract infection. Her parents report that she had been developing normally until $8$ months of age, but she subsequently lost the ability to sit unsupported and no longer babbles. Vital signs reveal a temperature of $37.6^\circ\text{C}$ ( $99.7^\circ\text{F}$ ), heart rate of $165/\text{min}$ , respiratory rate of $55/\text{min}$ , and blood pressure of $80/40\text{ mm Hg}$ . Physical examination is notable for marked hypotonia, diminished deep tendon reflexes, and deep, rapid, unlabored respirations without wheezing or crackles.

Laboratory studies show:
* Sodium: $138\text{ mEq/L}$
* Potassium: $4.8\text{ mEq/L}$
* Chloride: $102\text{ mEq/L}$
* Bicarbonate: $10\text{ mEq/L}$
* Blood glucose: $45\text{ mg/dL}$
* Blood urea nitrogen: $18\text{ mg/dL}$
* Creatinine: $0.4\text{ mg/dL}$

Arterial blood gas (room air):
* pH: $7.15$
* **PaCO $_2$ **: $28\text{ mm Hg}$
* **PaO $_2$ **: $98\text{ mm Hg}$

Urine organic acid analysis demonstrates massively elevated levels of methylmalonic acid.

Which of the following statements regarding this patient's condition and clinical presentation is most accurate?

The underlying etiology of this patient's metabolic crisis involves a deficient enzyme that utilizes cobalamin as an essential cofactor.

The arterial blood gas results demonstrate that the patient has successfully mounted the appropriate respiratory compensation for her acid-base disturbance.

The patient's current motor abilities, including her inability to sit without support, represent a normal physiologic variant of motor development for a 14-month-old child.

The patient's marked tachypnea in the setting of a viral prodrome suggests an acute asthma exacerbation requiring immediate administration of nebulized bronchodilators.

The most critical initial intervention is the empiric administration of broad-spectrum intravenous antibiotics to manage severe sepsis and prevent further decompensation.

Cevabı ve açıklamayı göster

Cevap: The underlying etiology of this patient's metabolic crisis involves a deficient enzyme that utilizes cobalamin as an essential cofactor.

Cevap

The underlying etiology of this patient's metabolic crisis involves a deficient enzyme that utilizes cobalamin as an essential cofactor.

The patient's clinical presentation of developmental regression, severe hypotonia, high anion gap metabolic acidosis (

26\text{ mEq/L}

), hypoglycemia, and elevated urine methylmalonic acid is diagnostic of methylmalonic acidemia. This organic acidemia is primarily caused by an autosomal recessive deficiency of the enzyme methylmalonyl-CoA mutase, which catalyzes the isomerization of L-methylmalonyl-CoA to succinyl-CoA for entry into the TCA cycle. This crucial enzymatic reaction requires vitamin B12 (cobalamin) in the form of adenosylcobalamin as an essential cofactor. In times of catabolic stress (such as a mild viral infection or fasting), the breakdown of odd-chain fatty acids and specific amino acids (valine, isoleucine, methionine, threonine) overwhelms the impaired pathway. This leads to a toxic accumulation of methylmalonic acid, resulting in the observed metabolic crisis, including hypoglycemia (due to secondary inhibition of gluconeogenesis) and profound high anion gap metabolic acidosis.

Adım Adım Çözüm

Calculate the anion gap to characterize the metabolic acidosis.

Anion gap =

138 - (102 + 10) = 26\text{ mEq/L}

. The patient has a high anion gap metabolic acidosis.

Evaluating the specific type of acid-base status is the critical first step in diagnosing the etiology of tachypnea and lethargy in an acutely ill infant.

Determine if respiratory compensation is adequate using Winter's formula.

Expected PaCO

_2 = (1.5 \times 10) + 8 = 23 \pm 2\text{ mm Hg}

. The measured PaCO

_2

28\text{ mm Hg}

, which is higher than expected. This indicates a superimposed primary respiratory acidosis.

Identifying mixed acid-base disorders is critical for recognizing impending respiratory failure in neuromuscularly compromised or profoundly hypotonic patients.

Synthesize the clinical presentation, laboratory findings, and motor milestone history.

The combination of a high anion gap metabolic acidosis, hypoglycemia, marked developmental regression (loss of sitting ability), hypotonia, and massively elevated methylmalonic acid confirms a diagnosis of methylmalonic acidemia.

The clinical triad of developmental regression, a severe metabolic crisis triggered by a minor illness, and specific urinary organic acids definitively points to this inborn error of metabolism.

Identify the underlying biochemical defect and its associated cofactor.

Methylmalonic acidemia is most commonly caused by a deficiency in methylmalonyl-CoA mutase. This enzyme specifically requires vitamin B12 (cobalamin) as a cofactor to function.

Understanding the biochemical pathway is necessary to determine potential targeted therapies, such as cobalamin supplementation for responsive forms of the disease.

Anahtar Kavram

Methylmalonic acidemia pathophysiology and diagnosis

Soru 10Soru →

A 9-month-old boy is brought to the pediatric clinic by his parents due to progressive lethargy, poor feeding, and loss of motor milestones over the past two months. Previously, he was able to sit without support, but he now has pronounced head lag and generalized weakness. Physical examination reveals a pale, apathetic infant with generalized hypotonia and a smooth, erythematous tongue. There is no hepatosplenomegaly, and no dysmorphic facial features are noted.

Laboratory studies are obtained and reveal the following:

Laboratory Test	Result	Reference Range
Hemoglobin	8.2 g/dL	10.5–13.5 g/dL
Mean corpuscular volume	108 fL	70–86 fL
Reticulocyte count	0.5%	0.5–1.5%
Vitamin B12 (cobalamin)	450 pg/mL	160–950 pg/mL
Folate	12 ng/mL	2.5–20.0 ng/mL
Homocysteine	85 µmol/L	5–15 µmol/L
Methylmalonic acid	14.2 µmol/L	0.0–0.4 µmol/L

Which of the following is the most likely primary underlying defect in this patient?

Impaired intracellular reduction and processing of cobalamin

Absent activity of methylmalonyl-CoA mutase

Decreased activity of cystathionine beta-synthase

Defective production of gastric intrinsic factor

Decreased activity of methylenetetrahydrofolate reductase

Cevabı ve açıklamayı göster

Cevap: Impaired intracellular reduction and processing of cobalamin

Cevap

The most likely underlying cause is an impaired intracellular reduction and processing of cobalamin, which prevents the formation of both active vitamin B12 coenzymes despite adequate serum B12 levels.

The correct answer describes a defect in the intracellular processing of vitamin B12 (cobalamin). Once vitamin B12 enters the target cells, it must be chemically reduced and processed to form two active coenzymes: methylcobalamin (required by methionine synthase to convert homocysteine to methionine) and adenosylcobalamin (required by methylmalonyl-CoA mutase to convert methylmalonyl-CoA to succinyl-CoA). An intracellular processing defect (such as cblC disease) prevents the synthesis of both coenzymes. This results in the accumulation of both homocysteine and methylmalonic acid, causing severe developmental regression, hypotonia, and megaloblastic anemia, even though the serum concentration of vitamin B12 is completely normal.

Adım Adım Çözüm

Analyze the complete blood count (CBC) and reticulocyte count.

The patient has a macrocytic anemia (high MCV, low hemoglobin) with an inappropriately low reticulocyte count, suggesting a megaloblastic process (typically folate or B12 dysfunction).

Identifying the mechanism of anemia narrows the differential to DNA synthesis defects, primarily involving the folate/B12 pathways.

Evaluate the serum vitamin levels.

Both serum vitamin B12 and folate levels are well within the normal reference ranges.

Normal serum levels rule out simple dietary deficiency, malabsorption (e.g., intrinsic factor deficiency), or transport defects in the gastrointestinal tract.

Interpret the specialized metabolic markers (homocysteine and methylmalonic acid).

Both plasma homocysteine and serum methylmalonic acid (MMA) are significantly elevated.

Elevated homocysteine indicates impaired methionine synthase activity (which requires methylcobalamin). Elevated MMA indicates impaired methylmalonyl-CoA mutase activity (which requires adenosylcobalamin).

Synthesize the biochemical data to identify the exact enzymatic block.

A defect upstream of both the methylcobalamin and adenosylcobalamin synthesis pathways is present inside the cell, despite adequate cobalamin in the blood.

This isolates the pathology to an intracellular cobalamin processing defect (most commonly the MMACHC gene mutation causing cblC disease), which presents in infancy with regression, hypotonia, and combined MMA/homocystinemia.

Anahtar Kavram

Intracellular cobalamin metabolism defects (e.g., cblC disease)

Soru 11Soru →

A $16$ -month-old boy is brought to the emergency department by his parents after they were unable to wake him up in the morning. For the past $48$ hours, the child has experienced a mild gastrointestinal illness characterized by vomiting and poor oral intake. Prior to this episode, he has been healthy and his developmental milestones are appropriate for his age. On physical examination, the child is lethargic and hypotonic, but has no rash, jaundice, or hepatosplenomegaly. Vital signs are within normal limits for his age, except for mild tachycardia. A point-of-care blood glucose measurement is $28$ mg/dL. Urinalysis is completely negative for ketones. Which of the following is the most appropriate next step in the management of this patient?

Immediate intravenous dextrose administration and subsequent evaluation for a fatty acid oxidation defect

Empiric administration of broad-spectrum antibiotics for suspected bacterial sepsis

Measurement of arterial blood gas to calculate the expected respiratory compensation

Referral for a comprehensive neurodevelopmental evaluation to assess for delayed milestones

Measurement of serum thyroid-stimulating hormone and free T4 levels

Cevabı ve açıklamayı göster

Cevap: Immediate intravenous dextrose administration and subsequent evaluation for a fatty acid oxidation defect

Cevap

Immediate intravenous dextrose administration and subsequent evaluation for a fatty acid oxidation defect

The patient presents with acute, severe hypoglycemia accompanied by an inappropriate absence of urinary ketones after a period of poor oral intake. This classic presentation of 'hypoketotic hypoglycemia' is highly suspicious for a fatty acid oxidation disorder, most commonly medium-chain acyl-CoA dehydrogenase (MCAD) deficiency. During fasting, the body normally breaks down fatty acids into acetyl-CoA, which is then converted into ketones to provide an alternative energy source for the brain. In MCAD deficiency, this process is impaired, leading to severe hypoglycemia without the expected compensatory ketone production. The immediate, life-saving next step is to restore blood glucose levels with intravenous dextrose, followed by a specific metabolic evaluation (such as an acylcarnitine profile) to confirm the diagnosis.

Adım Adım Çözüm

Evaluate the clinical presentation and laboratory findings.

The patient has profound hypoglycemia (

28

mg/dL) and absent urinary ketones after a period of fasting due to a viral illness.

Recognizing the combination of hypoglycemia and lack of ketones (hypoketotic hypoglycemia) is the critical step in differentiating the underlying metabolic mechanism.

Identify the likely underlying pathophysiological condition.

The inability to produce ketones during fasting hypoglycemia strongly points to an impairment in fatty acid beta-oxidation, such as medium-chain acyl-CoA dehydrogenase (MCAD) deficiency.

Fatty acid oxidation is physiologically required to generate ketones (an alternative brain fuel) and support gluconeogenesis when glycogen stores are depleted.

Determine the most appropriate immediate management.

Intravenous dextrose must be administered immediately to reverse the severe hypoglycemia, followed by specific metabolic diagnostic testing.

Hypoglycemia is a life-threatening emergency that must be corrected instantly to prevent permanent neurological injury, taking precedence over definitive diagnostic tests.

Anahtar Kavram

Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency and the management of hypoketotic hypoglycemia.

Soru 12Soru →

A 4-month-old boy is brought to the emergency department due to progressive feeding difficulties, a weak cry, and rapid breathing. Over the past month, his parents noticed he becomes exhausted and sweaty during feeds. He smiles socially and coos interactively, but he has not yet been able to roll over or hold his head up. His temperature is 37.1°C (98.8°F), blood pressure is 85/50 mm Hg, pulse is 165/min, and respiratory rate is 65/min. Physical examination reveals a lethargic infant with a protruding tongue and generalized hypotonia. When pulled to a sitting position, he exhibits severe head lag. Deep tendon reflexes are absent. Lung auscultation reveals bilateral basilar crackles and scattered wheezes. The liver edge is palpated 4 cm below the right costal margin. A chest radiograph demonstrates massive cardiomegaly. Electrocardiography shows short PR intervals and large QRS complexes.

Laboratory studies show:
Arterial blood gas:
pH: 7.30
pCO2: 54 mm Hg
Bicarbonate: 26 mEq/L

Serum creatine kinase: 1,850 U/L (normal: 22-198 U/L)

Which of the following is the most likely underlying etiology of this patient's clinical presentation?

Defective lysosomal degradation of glycogen

Deficient hepatic glucose-6-phosphatase

Progressive neuronal loss in the cerebral cortex and anterior horn cells

Viral inflammation of the bronchiolar epithelium

Bacterial infiltration of the myocardial interstitium

Cevabı ve açıklamayı göster

Cevap: Defective lysosomal degradation of glycogen

Cevap

Defective lysosomal degradation of glycogen

This patient's presentation of profound hypotonia, macroglossia, hypertrophic cardiomyopathy (massive cardiomegaly, short PR intervals), and markedly elevated creatine kinase is the classic presentation of Pompe disease (glycogen storage disease type II). Pompe disease is an autosomal recessive disorder caused by a deficiency of lysosomal acid alpha-glucosidase (also known as acid maltase). This enzyme is responsible for the degradation of glycogen into glucose within lysosomes. Its deficiency leads to toxic accumulation of glycogen primarily within cardiac and skeletal muscle tissue. The resulting muscle weakness accounts for the profound hypotonia, failure to attain motor milestones, and respiratory hypoventilation leading to the acute respiratory acidosis seen on this patient's blood gas.

Adım Adım Çözüm

Analyze the patient's neurological and developmental presentation.

The infant has profound generalized hypotonia, absent reflexes, and failure to reach motor milestones (head control, rolling over), while social and language milestones (smiling, cooing) remain perfectly normal for his age.

Differentiating between isolated motor weakness (myopathy or lower motor neuron disease) and global neurodevelopmental delay is critical.

Evaluate the cardiac and respiratory findings.

The patient has massive cardiomegaly, heart failure (crackles, hepatomegaly), and specific ECG changes (short PR, large QRS). The respiratory distress is accompanied by a primary respiratory acidosis (pH 7.30, elevated pCO2 54, normal bicarbonate 26).

Identifying hypertrophic cardiomyopathy combined with respiratory hypoventilation narrows the differential diagnosis significantly.

Synthesize the multisystem clinical picture with laboratory data.

The combination of a "floppy baby" with macroglossia, severe hypertrophic cardiomyopathy, elevated creatine kinase, and hypoventilation is the classic triad for Pompe disease.

This specific cluster of findings is pathognomonic for a specific inborn error of metabolism.

Identify the underlying molecular etiology of the identified syndrome.

Pompe disease is Glycogen Storage Disease type II, caused by a deficiency in lysosomal acid alpha-glucosidase (acid maltase), leading to defective lysosomal degradation of glycogen.

The question directly asks for the etiology corresponding to the clinical diagnosis.

Anahtar Kavram

Pompe disease (Glycogen storage disease type II) is a lysosomal storage disorder causing glycogen accumulation in cardiac and skeletal muscle, presenting in infancy with profound hypotonia, macroglossia, and severe hypertrophic cardiomyopathy.

Soru 13Soru →

Match the following classic clinical presentations with the most likely underlying pediatric genetic or metabolic disorder.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Cevabı ve açıklamayı göster

Cevap

Phenylketonuria matches with fair pigmentation and a musty odor; Tay-Sachs disease matches with a cherry-red macula and no hepatosplenomegaly; Niemann-Pick disease matches with a cherry-red macula and hepatosplenomegaly; Galactosemia matches with cataracts and liver failure upon milk exposure.

Matching these classic clinical vignettes to the correct metabolic disorder requires recognizing key differentiating physical findings. Tay-Sachs and Niemann-Pick both have cherry-red maculas, but Niemann-Pick involves hepatosplenomegaly. PKU is characterized by fair skin and a musty odor, while galactosemia uniquely presents with early neonatal cataracts and liver failure upon milk exposure.

Adım Adım Çözüm

Analyze the clinical features associated with the cherry-red macula presentations.

Differentiate between the presence and absence of hepatosplenomegaly.

Both Tay-Sachs and Niemann-Pick cause a cherry-red spot, but only Niemann-Pick causes organomegaly.

Identify the presentation linked to dietary milk exposure.

Match milk exposure, early cataracts, and jaundice to galactosemia.

Galactosemia is a classic disorder triggered early in life by ingestion of lactose/galactose.

Identify the presentation with distinct physical traits and odor.

Match fair skin, developmental delay, and a musty odor to Phenylketonuria.

PKU classically presents with hypopigmentation and a musty odor due to phenylalanine metabolite accumulation.

Anahtar Kavram

Clinical differentiation of classic pediatric metabolic and genetic disorders based on distinct physical examination findings.

Soru 14Soru →

A 10-month-old boy is brought to the pediatrician by his parents for a well-child check. The parents are concerned because he is not yet sitting without support and has stopped babbling. They also report that his diapers have a distinct "musty" odor. On physical examination, the boy is noted to have very fair skin, blonde hair, and blue eyes, which contrasts significantly with his parents' dark complexions. An intensely itchy, erythematous, scaly rash is present on his cheeks and the extensor surfaces of his arms. A basic metabolic panel is unremarkable. Assuming the diagnosis is confirmed, which of the following is the most appropriate long-term management for this patient's underlying condition?

Reassurance and routine follow-up for isolated motor delay

Application of topical mupirocin to the face and arms

Initiation of daily levothyroxine therapy

Restriction of dietary phenylalanine

Intravenous administration of sodium bicarbonate

Cevabı ve açıklamayı göster

Cevap: Restriction of dietary phenylalanine

Cevap

The most appropriate long-term management is the restriction of dietary phenylalanine.

The correct answer directly addresses the underlying pathophysiology of Phenylketonuria (PKU). This patient's presentation of developmental delay, a distinct 'musty' or 'mousy' odor, fair skin and hair (due to lack of tyrosine for melanin synthesis), and an eczematous rash is the classic clinical vignette for PKU. The primary, essential treatment to prevent progressive and irreversible intellectual disability is a strict, lifelong diet restricted in phenylalanine.

Adım Adım Çözüm

Identify the clinical syndrome based on the physical exam and history.

The patient has developmental delay, a 'musty' body odor, fair pigmentation (blonde hair, blue eyes), and eczema.

This specific combination of signs is the classic tetrad for Phenylketonuria (PKU).

Determine the underlying pathophysiology of the identified condition.

PKU is caused by a deficiency in the enzyme phenylalanine hydroxylase, leading to toxic accumulation of phenylalanine and decreased production of tyrosine (which causes the decreased melanin and fair pigmentation).

Understanding the biochemical defect dictates the therapeutic approach.

Select the most appropriate management.

The cornerstone of treatment is a lifelong diet restricted in phenylalanine, along with tyrosine supplementation.

This prevents further neurological damage and intellectual disability.

Anahtar Kavram

Phenylketonuria (PKU) presentation and management

Soru 15Soru →

A 4-day-old neonate is brought to the emergency department due to progressive lethargy, poor feeding, and vomiting. On examination, the infant is tachypneic, hypotonic, and difficult to arouse. A metabolic crisis secondary to an inborn error of metabolism, such as a urea cycle defect, is highly suspected. Arrange the following steps in the most appropriate chronological order for the acute management and diagnostic workup of this patient.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is: (1) Assess and stabilize ABCs, (2) Draw critical screening laboratory tests, (3) Discontinue protein and initiate intravenous dextrose, (4) Administer specific toxin-removal therapies.

In any pediatric emergency, especially suspected metabolic crises, the algorithm begins with the ABCs to ensure the patient does not succumb to acute cardiorespiratory failure. Following stabilization, obtaining blood for an ammonia level, blood gas, and glucose is critical because these values guide subsequent therapy and must be drawn before intravenous fluids potentially alter the results. Immediately after, the primary empiric treatment is to stop all protein intake and administer intravenous dextrose to promote anabolism and stop the breakdown of endogenous proteins, which fuels the metabolic crisis. Finally, once labs confirm severe hyperammonemia, specific interventions like nitrogen scavengers (e.g., sodium benzoate) or hemodialysis are instituted.

Adım Adım Çözüm

Ensure cardiorespiratory stability

Airway, breathing, and circulation are secured.

Life-threatening conditions must be addressed first in any critically ill patient.

Obtain diagnostic labs

Plasma ammonia, blood gas, and glucose are drawn.

Baseline diagnostic markers are necessary to confirm the specific type of metabolic crisis before empiric treatments potentially mask them.

Halt catabolism

Enteral protein is stopped and IV dextrose is started.

Providing a non-protein energy source reverses the catabolic state, which is the primary driver of toxic metabolite accumulation.

Remove accumulated toxins

Nitrogen scavengers or hemodialysis are initiated.

Once hyperammonemia or specific toxic accumulations are confirmed, targeted therapies are used to clear the toxins from the bloodstream.

Anahtar Kavram

The sequential management of a neonatal metabolic crisis prioritizes hemodynamic stabilization, followed by diagnostic blood draws, empiric reversal of catabolism, and finally targeted toxin removal.

Soru 16Soru →

A 3-day-old full-term boy is brought to the emergency department due to poor feeding, vomiting, and increasing lethargy over the past 12 hours. He was born via uncomplicated vaginal delivery and discharged at 48 hours of life after tolerating initial formula feeds. Temperature is 35.8°C (96.4°F), heart rate is 170/min, respiratory rate is 65/min, and blood pressure is 60/40 mm Hg. Physical examination reveals a somnolent infant with hypotonia and a bulging anterior fontanelle. Initial stat laboratory results show a blood glucose of 68 mg/dL and a serum ammonia level of 950 µmol/L (normal: 15-50 µmol/L). Arterial blood gas shows a pH of 7.50, pCO2 of 28 mm Hg, and HCO3 of 22 mEq/L. Arrange the following steps in the acute management and diagnostic workup of this patient in the most appropriate chronological order of execution.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct chronological sequence for managing severe neonatal hyperammonemia is: 1) Discontinue protein and start dextrose fluids, 2) Draw specific diagnostic labs, 3) Administer nitrogen scavengers, and 4) Initiate hemodialysis.

In a neonate with a suspected urea cycle defect and severe hyperammonemia, management must be swift and sequential. The primary goal is to stop ammonia production by discontinuing protein intake and providing dextrose to reverse catabolism. Simultaneously, but prior to initiating definitive clearance therapies, diagnostic labs (plasma amino acids, urine organic acids) must be drawn because clearance therapies will alter these profiles. Once drawn, pharmacologic nitrogen scavengers are administered immediately. Finally, because the ammonia level is profoundly elevated (> 500 µmol/L), hemodialysis is the only definitive way to clear the ammonia fast enough to prevent permanent brain damage, and preparations for it should follow initial medical stabilization.

Adım Adım Çözüm

Analyze the clinical presentation and initial laboratories.

The neonate has severe hyperammonemia (950 µmol/L) with respiratory alkalosis and no hypoglycemia. This is highly indicative of a urea cycle defect (such as Ornithine Transcarbamylase deficiency).

Identifying the severity of hyperammonemia dictates the urgency and modality of treatment required to prevent irreversible neurologic damage.

Determine the immediate first step in stabilization.

Discontinue enteral protein feeds and provide high-concentration dextrose intravenous fluids.

This halts exogenous nitrogen load and stimulates insulin release, reversing the catabolic state and preventing further endogenous protein breakdown.

Determine the optimal timing for diagnostic sampling.

Draw specific metabolic labs (amino acids, organic acids, orotic acid).

These must be drawn before administering scavenger medications or starting dialysis, as these treatments will rapidly alter the biochemical profile and obscure the underlying genetic defect.

Select the appropriate pharmacologic and procedural interventions.

Administer nitrogen scavengers followed by preparing for hemodialysis.

Intravenous scavengers (sodium benzoate/phenylacetate) can be started quickly to lower ammonia. However, for ammonia levels > 500 µmol/L, hemodialysis is definitively required and should be prepared concurrently.

Anahtar Kavram

Acute management of severe neonatal hyperammonemia requires immediate reversal of catabolism, collection of diagnostic labs prior to definitive treatment, administration of nitrogen scavengers, and hemodialysis for critically high levels.

Soru 17Soru →

During a routine well-child visit, a pediatrician evaluates a 15-month-old girl due to parental concerns regarding her development. She is currently unable to stand with support and exhibits minimal vocalizations. Physical examination reveals several dysmorphic features, including a broad nasal bridge, low-set ears, and a single transverse palmar crease. The physician suspects an underlying genetic etiology. Arrange the following steps in the diagnostic evaluation and management of this patient in the most appropriate sequential order, progressing from initial clinical assessment to definitive management.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence begins with a detailed family and prenatal history, followed by chromosomal microarray analysis (CMA) as the first-tier test, whole-exome sequencing (WES) if CMA is unrevealing, and concludes with targeted multidisciplinary management once a definitive diagnosis is established.

The evaluation of a child with global developmental delay and dysmorphic features requires a stepwise approach. It must begin with a thorough history (including a three-generation pedigree). Current pediatric genetics guidelines strongly recommend chromosomal microarray analysis (CMA) as the first-tier test for unexplained developmental delay and multiple congenital anomalies, as it detects microscopic copy number variants that a standard karyotype would miss. If CMA is non-diagnostic, second-tier testing such as whole-exome sequencing is then pursued. Finally, diagnosis-specific multidisciplinary management and family counseling are implemented.

Adım Adım Çözüm

Gather detailed clinical information.

Creation of a three-generation pedigree and review of prenatal exposures.

Establishes baseline risk and identifies potential familial inheritance patterns.

Perform first-tier genetic testing.

Chromosomal microarray analysis (CMA) is ordered.

CMA has the highest diagnostic yield for detecting copy number variants (microdeletions and microduplications) in children with dysmorphic features and developmental delay.

Escalate to second-tier testing if necessary.

Whole-exome sequencing (WES) is ordered.

Used to identify single-gene mutations if the initial broad screening with CMA does not yield a diagnosis.

Implement targeted management.

Referrals to appropriate specialists (e.g., early intervention, cardiology) and genetic counselors.

Ensures the patient receives syndrome-specific care and the family understands recurrence risks for future pregnancies.

Anahtar Kavram

Chromosomal microarray analysis (CMA) is the first-line genetic test for children presenting with unexplained global developmental delay and dysmorphic features.

Soru 18Soru →

A 6-month-old girl of Ashkenazi Jewish descent is brought to the pediatrician due to parental concerns about her development. The parents report that she was previously able to roll over and reach for objects, but she has lost these abilities over the past month. Physical examination reveals hypotonia, a protuberant abdomen with palpable hepatosplenomegaly, and decreased deep tendon reflexes. Funduscopic examination demonstrates a bilateral cherry-red spot on the macula. Which of the following enzymes is most likely deficient in this patient?

Sphingomyelinase

Hexosaminidase A

Glucocerebrosidase

Alpha-galactosidase A

Galactocerebrosidase

Cevabı ve açıklamayı göster

Cevap: Sphingomyelinase

Cevap

Sphingomyelinase

The patient's presentation of developmental regression, a cherry-red macula, and hepatosplenomegaly is the classic triad for Niemann-Pick disease type A. This autosomal recessive lysosomal storage disorder is caused by a deficiency of the enzyme sphingomyelinase, leading to the accumulation of sphingomyelin in macrophages (resulting in foam cells) and various tissues, including the liver, spleen, and central nervous system.

Adım Adım Çözüm

Identify the key clinical features in the vignette.

The patient has developmental regression, hepatosplenomegaly, and a cherry-red macula.

Recognizing this classic triad is essential for diagnosing the specific lysosomal storage disease.

Differentiate between diseases causing a cherry-red macula.

Both Tay-Sachs disease and Niemann-Pick disease type A present with a cherry-red macula and developmental regression. However, only Niemann-Pick disease causes hepatosplenomegaly.

Hepatosplenomegaly distinguishes Niemann-Pick from Tay-Sachs.

Recall the enzyme deficiency for the identified disease.

Niemann-Pick disease type A is caused by a deficiency of sphingomyelinase.

Matching the clinical syndrome to its underlying enzymatic defect.

Anahtar Kavram

Niemann-Pick disease type A is an autosomal recessive lysosomal storage disorder caused by sphingomyelinase deficiency, classically presenting in infancy with developmental regression, hepatosplenomegaly, and a cherry-red macula.

Soru 19Soru →

A 9-day-old female infant is admitted to the neonatal intensive care unit for profound lethargy, tachypnea, and recurrent vomiting. She was born at full term via uncomplicated delivery and appeared well until two days ago when breastfeeding was supplemented with a cow's milk-based formula. On examination, the infant is unresponsive to tactile stimuli and exhibits generalized hypotonia.

Laboratory studies are as follows:

Test	Result
Arterial Blood Gas
pH	7.18
$pCO_2$	18 mm Hg
$pO_2$	98 mm Hg
Serum Chemistry
Sodium	142 mEq/L
Potassium	5.1 mEq/L
Chloride	99 mEq/L
Bicarbonate	7 mEq/L
Blood urea nitrogen	14 mg/dL
Creatinine	0.3 mg/dL
Glucose	48 mg/dL
Ammonia	720 $\mu$ mol/L (normal: 15-50 $\mu$ mol/L)
Urinalysis
Ketones	+++
Reducing substances	Negative

Restriction of which of the following groups of amino acids is most critical for the long-term management of this patient's underlying condition?

Leucine, isoleucine, and valine

Methionine, threonine, and valine

Phenylalanine and tyrosine

Arginine and citrulline

Lysine and tryptophan

Cevabı ve açıklamayı göster

Cevap: Methionine, threonine, and valine

Cevap

Methionine, threonine, and valine

The correct answer identifies the amino acids that feed into the propionyl-CoA metabolic pathway. This patient's clinical presentation (neonatal encephalopathy after a protein load) and laboratory findings (severe high anion gap metabolic acidosis, ketonuria, hypoglycemia, and massive hyperammonemia) are the hallmark features of an organic acidemia, most likely propionic acidemia or methylmalonic acidemia. The hyperammonemia in organic acidemias is secondary to the toxic inhibition of the urea cycle enzyme carbamoyl phosphate synthetase I (CPS-I) by accumulating organic acid intermediates. Because the defect lies in the metabolism of propionyl-CoA to succinyl-CoA, treatment involves a low-protein diet strictly restricting the precursors to propionyl-CoA. These precursors include Valine, Odd-chain fatty acids, Methionine, Isoleucine, and Threonine.

Adım Adım Çözüm

Analyze the acid-base status and calculate the anion gap.

The patient has a severe metabolic acidosis (pH 7.18, HCO3 7 mEq/L) with appropriate respiratory compensation (

pCO_2

18 mm Hg). The anion gap is 142 - (99 + 7) = 36 mEq/L, indicating a primary high anion gap metabolic acidosis.

Differentiating between causes of neonatal encephalopathy requires classifying the primary acid-base disturbance.

Interpret the associated laboratory findings in the context of the acidosis.

The patient has marked hyperammonemia (720

\mu

mol/L), ketotic hypoglycemia (glucose 48 mg/dL, positive urine ketones), and encephalopathy following the introduction of standard formula (protein load).

The combination of high anion gap metabolic acidosis, hyperammonemia, and ketonuria points toward a specific category of inborn errors of metabolism.

Differentiate organic acidemias from urea cycle defects (UCDs) and fatty acid oxidation defects (FAODs).

UCDs cause primary respiratory alkalosis without primary acidosis. FAODs cause hypoketotic hypoglycemia. The presence of high anion gap metabolic acidosis with ketonuria and massive secondary hyperammonemia is diagnostic for an organic acidemia.

Accurate categorization allows for identification of the underlying defective metabolic pathway.

Identify the affected metabolic pathway and necessary dietary modifications.

Propionic and methylmalonic acidemias result from defects in the breakdown of propionyl-CoA. The precursors for this pathway are Valine, Odd-chain fatty acids, Methionine, Isoleucine, and Threonine (VOMIT). Therefore, these specific amino acids must be restricted in the diet.

Long-term management of organic acidemias requires limiting the specific precursors that cannot be metabolized.

Anahtar Kavram

Neonatal presentation of organic acidemias (e.g., methylmalonic or propionic acidemia) features high anion gap metabolic acidosis, ketotic hypoglycemia, and secondary hyperammonemia. Management requires restricting precursor amino acids that feed into propionyl-CoA: Valine, Methionine, Isoleucine, and Threonine.

Soru 20Soru →

Match each classic pediatric clinical presentation with the corresponding defective enzyme.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Cevabı ve açıklamayı göster

Cevap

The neonate with sweet-smelling urine matches Branched-chain alpha-keto acid dehydrogenase. The boy with a musty odor matches Phenylalanine hydroxylase. The girl with a marfanoid habitus and thrombosis matches Cystathionine beta-synthase. The infant with dark urine matches Homogentisate oxidase.

Each pediatric metabolic disorder is matched to its corresponding enzymatic defect based on distinct, highly tested pathognomonic clinical signs: burnt sugar odor (MSUD), musty odor (PKU), marfanoid habitus with thrombosis (Homocystinuria), and dark urine (Alkaptonuria).

Adım Adım Çözüm

Analyze the first clinical presentation (burnt sugar odor, lethargy).

Identify as Maple Syrup Urine Disease.

The distinctive odor of branched-chain amino acids in the urine strongly points to an inability to break down leucine, isoleucine, and valine.

Analyze the second presentation (musty odor, fair pigmentation, intellectual disability).

Identify as Phenylketonuria (PKU).

Accumulation of phenylalanine causes the musty odor, and decreased tyrosine (and subsequently melanin) synthesis leads to fair skin.

Analyze the third presentation (marfanoid body, thrombosis, downward lens subluxation).

Identify as Homocystinuria.

Thrombosis and downward lens subluxation differentiate this disorder from Marfan syndrome, pointing to an underlying amino acid metabolism defect.

Analyze the fourth presentation (urine darkening upon standing).

Identify as Alkaptonuria.

Homogentisic acid oxidizes in the air, causing the classic black discoloration of urine.

Anahtar Kavram

Clinical recognition and biochemical etiology of classic pediatric amino acid disorders.

Sayfa 1 / 3Sonraki

Pediatric Genetic and Metabolic Disorders

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Cevap

Adım Adım Çözüm

Anahtar Kavram